Yolanda Lenzy, MD
Dermatology Physician in Chicopee, Massachusetts.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 14,645 in Dermatology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Yolanda Lenzy, MD filed 2,203 Medicare Part D claims in 2023 as a Dermatology Physician in Chicopee, Massachusetts, prescribing 82% generic.
- 2K
- Part D claims, 2023
- 82%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Yolanda Lenzy, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
2,203 Top 15% higher than 85% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
Yolanda Lenzy, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Yolanda Lenzy, MD?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Massachusetts
How Dermatology Physician compares to other specialties among Massachusetts providers
Dermatology Physician ranks #56 among Massachusetts's specialties (0.3% of in-state providers)
Each bar is a specialty's share of the Massachusetts provider total, by primary NUCC taxonomy. The highlighted bar is Dermatology Physician; the long tail of smaller specialties is omitted for legibility.
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Dermatology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Yolanda Lenzy, MD appears in the CMS NPPES registry as a Dermatology Physician provider holding MD credentials at 1176 MEMORIAL DR, Chicopee, MA, 01020, with a listed phone of (413) 331-3676. NPI 1992831309 was issued on 02/27/2007.
Medicare Part D records for calendar year 2023 show 2,203 prescription claims written by this provider, covering 444 Medicare beneficiaries and totaling roughly $2.5 million in drug spend, split 18% brand-name and 82% generic by claim count.
Dermatology Physician is a mid-sized specialty nationwide, with 14,645 enrolled providers across 53 states and an average of 729 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1992831309 |
|---|---|
| Specialty | Dermatology Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 02/27/2007 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Yolanda Lenzy, MD's current license status, disciplinary history, and board certifications with the Massachusetts Board of Registration in Medicine in Massachusetts before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1992831309 is the unique 10-digit identifier CMS uses to link Lenzy across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
Hospital and facility affiliations
Facilities where Yolanda Lenzy, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Yolanda Lenzy, MD. Source: openpaymentsdata.cms.gov.
Total received
$3.3K
Largest payer
Lilly USA, LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Massachusetts BORIM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 - they are NOT specific to Yolanda Lenzy, MD. To verify Yolanda Lenzy, MD's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
18% brand-name claims vs 82% generic, on 2,203 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 2,814
- Total Day Supply
- 79,231
- Brand vs Generic
- 18% brand / 82% generic
- Brand Drug Cost
- $2.4M
- Generic Drug Cost
- $64K
- Antibiotic Claims
- 127
Patient Demographics
- Average Patient Age
- 66.0 years
- Avg HCC Risk Score
- 1.19
- Gender Split
- 75% female / 25% male
- Age Distribution
- <65: 151, 65-74: 185, 75-84: 88, 85+: 20
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Yolanda Lenzy, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Betamethasone Dipr…
Betamethasone Dipropionate
240 claims
- Minoxidil
Minoxidil
240 claims
- Ketoconazole
Ketoconazole
237 claims
- Fluocinonide
Fluocinonide
164 claims
- Doxycycline Hyclate
Doxycycline Hyclate
98 claims
- Hydrocortisone 90
Hydrocortisone
90 claims
- Triamcinolone Acet… 89
Triamcinolone Acetonide
89 claims
- Clindamycin Phosph… 80
Clindamycin Phosphate
80 claims
| Drug | Claims |
|---|---|
| Betamethasone Dipropionate | 240 |
| Minoxidil | 240 |
| Ketoconazole | 237 |
| Fluocinonide | 164 |
| Doxycycline Hyclate | 98 |
| Hydrocortisone | 90 |
| Triamcinolone Acetonide | 89 |
| Clindamycin Phosphate | 80 |
| Clobetasol Propionate | 76 |
| Otezla Apremilast | 66 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Dermatology Physician Overview
How Yolanda Lenzy, MD fits within the Dermatology Physician landscape nationally.
Yolanda Lenzy, MD's 2,203 claims are above the specialty average of 729.
Nearby Dermatology Physician Providers in Massachusetts
Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as Lenzy.
Compare Dermatology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Massachusetts medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Dermatology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Massachusetts
Frequently Asked Questions
What is Yolanda Lenzy, MD's specialty? ▼
How much does Yolanda Lenzy, MD prescribe under Medicare Part D? ▼
Where is Yolanda Lenzy, MD located? ▼
What is Yolanda Lenzy, MD's NPI number? ▼
Does Yolanda Lenzy, MD prescribe more brand-name or generic drugs? ▼
How many Dermatology Physician providers are there in the US? ▼
What drugs does Yolanda Lenzy, MD prescribe most often? ▼
Does Yolanda Lenzy, MD accept Medicare? ▼
How can I verify Yolanda Lenzy, MD's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor Editorial
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.